Event

28

November 2019

What Will the Next 1,461 Days of the New Government Mean for Healthcare?

11:30am-1:30pm | The Fairmont Royal York - 100 Front Street West, Toronto

Canadians are concerned about our healthcare system – from growing wait times, to what universal healthcare really means for Canada. Right now, five million Canadians are living with diabetes and six million more are at risk of developing it soon. Today, one Canadian is diagnosed with this progressive, chronic disease every three minutes. By any definition, a disease affecting this proportion of our population is an epidemic.

- Lunch will be served -

Member price:
Individual seat: $89 +HST
Table (seats 10): $800 +HST

Regular price:
Individual seat: $110 +HST
Table (seats 10): $990 +HST

Important:
- For information about accessibility, please email nefisa@economicclub.ca
- Dietary restriction notes and meal requests must be submitted to nefisa@economicclub.ca at least 48 hrs before the event.
- Refunds/credits: We require three business days notice in advance of the event date for ticket cancellations

*The views expressed on the Economic Club platform are not that of the Economic Club or its affiliates but of the speakers alone and the organizations they represent*

What Will the Next 1,461 Days of the New Government Mean for Healthcare?

André Picard

Health Columnist
The Globe and Mail

André Picard

André Picard is the health columnist at The Globe and Mail, where he has been a staff writer since 1987.

He is also the author of five books. His current bestseller is a collection of columns entitled “Matters of Life and Death: Public Health Issues in Canada.”

André is a graduate of the University of Ottawa and Carleton University and has received honorary doctorates from six universities, most recently the U of T.

Dr. Jan Hux

President & CEO
Diabetes Canada

Dr. Jan Hux

Dr. Hux began her journey within the field of diabetes after graduating with a Doctor of Medicine degree from the University of Toronto and a Master of Science in Epidemiology from Harvard School of Public Health. She is a clinician-scientist and trained as a general internist and health services researcher.

For more than 20 years, Dr. Hux has had a long-standing affiliation with the Institute for Clinical Evaluative Sciences (ICES) in Ontario, as a trainee, scientist, chief operating officer and finally Deputy CEO and Senior Director, Public Relations and Partnerships. Within these positions, she was responsible for developing and leading the diabetes health services research portfolio.

She has published more than 100 peer-reviewed papers, currently holds an Adjunct Scientist appointment at ICES, and is an Adjunct Professor at the University of Toronto in the Departments of Medicine and Health Policy, Management and Evaluation. As an adjunct professor, Dr. Hux has taken the time to mentor female medical students, seeing them through medical school, residency and then on to becoming successful diabetes researchers.

Dr. Hux joined Diabetes Canada in 2012 as the Chief Scientific Advisor. In this role, she provided strategic leadership for the organization and in particular for the research and professional education portfolios, which includes the development and dissemination of Clinical Practice Guidelines. She has also acted as the organization’s media spokesperson. Her contributions to the management and strategic direction of the organization led to Dr. Hux’s appointment as President and CEO of Diabetes Canada in 2018.

Dr. Mansoor Husain

Professor of Medicine, Physiology & Laboratory Medicine & Pathobiology
University Health Network and University of Toronto

Dr. Mansoor Husain

Dr. Mansoor Husain was the Gold Medalist in Medicine with Distinction at the University of Alberta (1986). After Residencies in Internal Medicine and Cardiology at the University of Toronto, Dr. Husain undertook Postdoctoral Studies in the Department of Biology at the Massachusetts Institute of Technology (1993-7), and in the Joint Program in Nuclear Medicine at Harvard Medical School.

Dr. Husain returned to the University Health Network (UHN) and the University of Toronto in 1997, where he is now Professor of Medicine, Physiology and Laboratory Medicine & Pathobiology (2011), and Director of the Toronto General Research Institute (2011), and Executive Director of the Ted Rogers Centre for Heart Research (2014).

Dr. Husain’s research is focused on the molecular mechanisms of cardiovascular disease, and has attracted operating funds from the Canadian Institutes of Health Research, the Heart & Stroke Foundation of Ontario, the Canada Foundation for Innovation, and the pharmaceutical industry.

Dr. Husain has been recognized by research awards from the Clinical Research Society of Toronto, University of Toronto, University of Manitoba, and the Ontario Premier’s Research Excellence Award. Dr. Husain has held the prestigious Clinician Scientist Award of the Canadian Institutes of Health Research (CIHR), the Career Investigator Award of the Heart and Stroke Foundation of Ontario, as well as uninterrupted operating grant support from these agencies since 1997.

Clinically, Dr. Husain is an attending physician in the Cardiac Intensive Care Unit of the Toronto General Hospital and the Nuclear Cardiology Laboratories of the University Health Network.

Our Sponsors

porter Interac Canadian Bankers Association pwc
BestLifeRewarded Innovations Boyden
CPA Bespoke Audio Visual Capital One